Event Driven Pharma: Shire Plc (SHP LN)
Worth speculating in the current environment - BUY
SHP LN: GBP 32.63 – tgt GBP 50.00
April 30, 2014
Shire is currently the focus of intense bid speculation. Given the “hot environment” in the pharma sector, Shire certainly fits the bill as a potential buy-out candidate. Its market cap is digestible ($32bn), the company is not controlled (unlike Meda or UCB for example), and it has an attractive portfolio which makes it one of the fastest growing pharma stocks. Moreover, and this is key for us to recommend the stock, Shire is significantly undervalued, particularly against other “deal stocks’ in the sector. Hence, we recommend a position in the name. Our target is significantly above the current share price, at GBP 50.0
FULL REPORT ATTACHED
From: LAURENT CHEKROUN ()
To: LAURENT CHEKROUN ()
At: Apr 29 2014 16:24:12
AFR has a decent rebound today, after few days correction, the stock is breaking important levels, important resistance on 154.30/155 levels that was my target.I will take part of profit above 154.50 but still think there is more potential, if 155 broken on close, target is 163.----- Original Message -----
From: LAURENT CHEKROUN ()
To: LAURENT CHEKROUN ()
At: Apr 28 2014 10:45:43AFR tested its 200d MA Last week and traded lower since that, PMO News over the Week end & Tullow article in teh Barron's are positive catalyst for the sector, Stock is testing some support , I will take profit around the 154.5 levels, if 156.75 broken next levels will be 164.AFR is still more than 4% higher since we initiate the trade.----- Original Message -----
From: LAURENT CHEKROUN ()
At: Apr 23 2014 13:49:29AFR +6.8% since recommendation on the 16th, still think there is more potential even if target reached, 155 next target----- Original Message -----
From: LAURENT CHEKROUN ()
To: LAURENT CHEKROUN ()
At: Apr 16 2014 16:46:46* Afren enjoyed a successful year in 2013, ramping up Ebok and capping the year off with the Ogo discovery* Kurdistan has been an early investment for Afren, and this asset could be sold and unlock value for shareholder, if no deal the stock should trade at least in line with the market* Stock is trading with a decent discount to NPV* 135 levels is a strong support and stock should hold these levels* Stosk has been weak on the last few weeks and start to stabilize* 2 brokers issued +ve recommendaation on the last 2 days (BMO & Investec)* I see limited downside (132 level - 5% from here ) and see the stoc testing back the 145 & 149 levels.as rumors were around on TLW stating Sinopec & Statoil could be interested, any news in the sector will push the stock higher.--> Buy Afren